SEC Form 5 · accession 0001567619-19-002398
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan W Ayers
Officer — Chairman, President & CEO · Director
Period of report
Dec 31, 2018
Accepted (ET)
Feb 5, 2019 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 28, 2018 | G | 4,200 | $0.00 | D | 1,031,322 | D | |
| Common Stock | holding | — | — | — | 138,000 | I | by Ayers Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 25 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on December 31, 2018.